Omega Fund Management as of Sept. 30, 2025
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 12 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kestra Med Technologies Common Stock (KMTS) | 17.6 | $39M | 1.6M | 23.76 | |
| Beta Bionics Common Stock (BBNX) | 17.2 | $38M | 1.9M | 19.87 | |
| BridgeBio Oncology Therapeutics Common Stock | 17.1 | $38M | 3.3M | 11.58 | |
| Bicara Therapeutics Common Stock (BCAX) | 15.7 | $35M | 2.2M | 15.79 | |
| Nuvation Bio Common Stock Class A (NUVB) | 14.7 | $33M | 8.8M | 3.70 | |
| Upstream Bio Common Stock (UPB) | 11.5 | $26M | 1.4M | 18.81 | |
| ImageneBio Common Stock | 1.7 | $3.7M | 455k | 8.15 | |
| enGene Holdings Common Stock (ENGN) | 1.6 | $3.6M | 526k | 6.83 | |
| Sana Biotechnology Common Stock (SANA) | 1.3 | $3.0M | 844k | 3.55 | |
| Alumis Common Stock (ALMS) | 1.2 | $2.6M | 653k | 3.99 | |
| Replimune Group Common Stock (REPL) | 0.5 | $1.0M | 249k | 4.19 | |
| enGene Holdings Warrant (ENGNW) | 0.0 | $63k | 90k | 0.71 |
